Robert M. Levande

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Founded in 1979 by Ralph Worthington and several other senior officers of Blyth Eastman Dillon, Gilford Securities, Inc. is an investment banking firm and registered broker/dealer located in New York City. The firm provides a variety of services to corporations, individuals and institutions. Their research approach is based on fundamental analysis and seeks to remain attentive to market sentiment. Gilford Securities seeks to provide sound financial advice that translates into superior returns for their clients. The firm's research efforts focus concentrates on small/mid-cap growth ideas, specifically, niche/international leaders that stand to benefit from long-term secular trends. Gilford Securities' research coverage includes spans multiple industries, with primary emphasis on the following sectors: (1) information technology and e-Commerce (2) energy (3) retail, consumer and specialty (4) chemicals and pharmaceuticals (5) clean technology and alternative energy and (6) consumer and business services.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Founded in 1979 by Ralph Worthington and several other senior officers of Blyth Eastman Dillon, Gilford Securities, Inc. is an investment banking firm and registered broker/dealer located in New York City. The firm provides a variety of services to corporations, individuals and institutions. Their research approach is based on fundamental analysis and seeks to remain attentive to market sentiment. Gilford Securities seeks to provide sound financial advice that translates into superior returns for their clients. The firm's research efforts focus concentrates on small/mid-cap growth ideas, specifically, niche/international leaders that stand to benefit from long-term secular trends. Gilford Securities' research coverage includes spans multiple industries, with primary emphasis on the following sectors: (1) information technology and e-Commerce (2) energy (3) retail, consumer and specialty (4) chemicals and pharmaceuticals (5) clean technology and alternative energy and (6) consumer and business services.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Founded in 1979 by Ralph Worthington and several other senior officers of Blyth Eastman Dillon, Gilford Securities, Inc. is an investment banking firm and registered broker/dealer located in New York City. The firm provides a variety of services to corporations, individuals and institutions. Their research approach is based on fundamental analysis and seeks to remain attentive to market sentiment. Gilford Securities seeks to provide sound financial advice that translates into superior returns for their clients. The firm's research efforts focus concentrates on small/mid-cap growth ideas, specifically, niche/international leaders that stand to benefit from long-term secular trends. Gilford Securities' research coverage includes spans multiple industries, with primary emphasis on the following sectors: (1) information technology and e-Commerce (2) energy (3) retail, consumer and specialty (4) chemicals and pharmaceuticals (5) clean technology and alternative energy and (6) consumer and business services.